论文标题
可扩展的脂质液滴微阵列制造,验证和筛选
Scalable lipid droplet microarray fabrication, validation, and screening
论文作者
论文摘要
小分子和天然产物的高吞吐量筛选成本很高,需要大量的时间,试剂和操作空间。尽管事实证明,微阵列可以有效地筛选某些生化测定法,例如核酸杂交或抗体结合,但由于细胞需要内化亲脂性药物候选者,它们并未广泛用于细胞培养的药物发现。脂质液滴微阵列是该问题的有前途的解决方案,因为它们能够以与溶液递送相当的剂量向细胞输送亲脂性药物。但是,阵列制造,测定验证和筛选步骤的可伸缩性限制了该方法的实用性。在这里,我们证明了脂质液滴阵列制造,细胞培养中的测定验证和药物筛查的可扩展过程。已对纳米纳特(Nanointaglio)打印过程进行了调整,可与打印压力机一起使用。使用蒸气涂层工艺稳定阵列,以浸入水溶液中。除了递送亲脂化合物外,我们还发现我们还能够以这种方式封装并递送水溶性化合物。这些阵列可以通过细胞外基质蛋白(如细胞培养之前的胶原蛋白)进行功能化,因为摄取机制是基于与脂质递送车的直接接触,而不是从微阵列中扩散药物。我们证明了这种方法,用于将3种不同的细胞类型递送,并在覆盖小于0.1 cm2的区域的微阵列上筛选90种天然产物提取物。该阵列适用于小型化筛选,例如在空间有限的BSL-3条件下,对于细胞数量有限的应用,例如功能精确医学。
High throughput screening of small molecules and natural products is costly, requiring significant amounts of time, reagents, and operating space. Although microarrays have proven effective in the miniaturization of screening for certain biochemical assays, such as nucleic acid hybridization or antibody binding, they are not widely used for drug discovery in cell culture due to the need for cells to internalize lipophilic drug candidates. Lipid droplet microarrays are a promising solution to this problem as they are capable of delivering lipophilic drugs to cells at dosages comparable to solution delivery. However, the scalablility of the array fabrication, assay validation, and screening steps has limited the utility of this approach. Here we demonstrate a scalable process for lipid droplet array fabrication, assay validation in cell culture, and drug screening. A nanointaglio printing process has been adapted for use with a printing press. The arrays are stabilized for immersion into aqueous solution using a vapor coating process. In addition to delivery of lipophilic compounds, we found that we are also able to encapsulate and deliver a water-soluble compound in this way. The arrays can be functionalized by extracellular matrix proteins such as collagen prior to cell culture as the mechanism for uptake is based on direct contact with the lipid delivery vehicles rather than diffusion of the drug out of the microarray spots. We demonstrate this method for delivery to 3 different cell types and the screening of 90 natural product extracts on a microarray covering an area of less than 0.1 cm2. The arrays are suitable for miniaturized screening, for instance in BSL-3 conditions where space is limited and for applications where cell numbers are limited, such as in functional precision medicine.